Laboratory Products
Amersham ECL Prime Chemiluminescent Western Blotting Reagent
Nov 25 2011
Highly sensitive, stable detection of small protein quantities GE Healthcare has introduced Amersham™ ECL™ Prime, a highly sensitive reagent characterised by stable signal emission up to 3 hours after addition of the reagent, allowing for the possibility of repeated exposures and making it easier to process several blots in the same experimental run. High signal intensity means that proteins may be detected using more dilute primary and secondary antibodies, which reduces background noise and reagent consumption.
Amersham ECL Prime is optimised for CCD based imaging with ImageQuant™ LAS 4000, and is compatible with Amersham Hyperfilm™. The reagent is optimised for use with Amersham Hybond™-P (PVDF) membranes and compatible with Amersham Hybond-ECL (nitrocellulose) membranes and for any other standard films and membranes..
GE Healthcare’s enhanced chemiluminescence (ECL) Western Blotting System portfolio provides tools for applications ranging from routine protein detection to multiplex analysis using fluorescence-based Amersham ECL Plex™. It is a workflow solution for faster, more sensitive and more flexible protein analysis.
Digital Edition
Lab Asia 31.4 August 2024
August 2024
Chromatography Articles - HPLC gradient validation using non-invasive flowmeters Mass Spectrometry & Spectroscopy Articles - MS detection of Alzheimer’s blood-based biomarkers Labo...
View all digital editions
Events
Sep 11 2024 Bangkok, Thailand
Sep 11 2024 Bangkok, Thailand
Sep 11 2024 Singapore
Sep 18 2024 Lausanne, Switzerland
Sep 19 2024 Shanghai, China